ClinVar Miner

Submissions for variant NM_000419.5(ITGA2B):c.460_462del (p.Glu154del)

dbSNP: rs747956782
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV001225281 SCV001397551 likely pathogenic Glanzmann thrombasthenia 2023-05-16 reviewed by expert panel curation The NM_000419.5(ITGA2B):c.460_462del deletion variant results in the in-frame deletion of Glu154 (PM4). It has been observed, in the homozygous state, in at least one case (PMID: 29675921; PM3_supporting) meeting the clinical and laboratory criteria of Glanzmann thrombasthenia, including mucocutaneous bleeding, impaired aggregation with all agonists except ristocetin, and reduced surface expression of αIIbβ3 measured by flow cytometry (PP4_strong). This variant occurs at an extremely low frequency with an overall allele frequency from gnomAD of 0.000004017 and MAF of 0.000008870 in the non-Finnish European population (PM2_supporting). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PP4_strong, PM2_supporting, PM3_supporting, PM4, PP4_strong. (VCEP specifications version 2).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.